News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
2don MSN
Rep. Marjorie Taylor Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine, describing the move as "Not ...
MedPage Today on MSN1d
CDC Expert Resigns From COVID Vax Role; FDA to Probe Abortion Drug; Measles UpdateA top CDC official said she was resigning from her role overseeing updates to the agency's COVID-19 vaccine recommendations ...
Key Takeaways Moderna said the FDA approved its new COVID-19 vaccine "for use in all adults 65 and older, as well as ...
"Political directives should not prevent individuals from seeking safe and effective care that they desire and deserve," ...
Moderna’s newest lower-dose COVID-19 vaccine is approved for all adults 65 and older, and for people aged 12 to 64 who are at ...
FDA Commissioner Dr. Martin A. Makary said the agency is taking aggressive steps to modernize outdated regulations, expand ...
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.
The World Health Organization has tracked a new COVID-19 variant that has emerged across multiple region. Amid this, the Food ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback